Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health [Internet]. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2023 [cited 2023 Nov 22]. Available from: https://www.samhsa.gov/data/report/2022-nsduh-annual-national-report. Accessed 22 Nov 2023

Spencer MR, Miniño AM, Warner M. Drug overdose deaths in the United States, 2001–2021 [Internet]. National Center for Health Statistics; 2022 [cited 2022 Dec 30]. Available from: https://doi.org/10.15620/cdc:122556

Barry CL, Epstein AJ, Fiellin DA, Fraenkel L, Busch SH. Estimating demand for primary care-based treatment for substance and alcohol use disorders. Addict Abingdon Engl 2016;111(8):1376–84.

Article  Google Scholar 

Moallef S, Dale L, Homayra F, et al. Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform. J Subst Abuse Treat 2022;139:108784.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kendall CE, Boucher LM, Donelle J, et al. Engagement in primary health care among marginalized people who use drugs in Ottawa, Canada. BMC Health Serv Res 2020;20:837.

Article  PubMed  Google Scholar 

Meyerson BE, Russell DM, Kichler M, Atkin T, Fox G, Coles HB. I don’t even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019. Int J Drug Policy 2021;93:103112.

Article  PubMed  Google Scholar 

Dion K, Chiodo L, Whynott L, et al. Exploration of the unmet health care needs of people who inject drugs. J Am Assoc Nurse Pract 2020;32(1):60–9.

Article  PubMed  Google Scholar 

Jackson LA, McWilliam S, Martin F, et al. Key challenges in providing services to people who use drugs: The perspectives of people working in emergency departments and shelters in Atlantic Canada. Drugs Educ Prev Policy 2014;21(3):244–53.

Article  Google Scholar 

Motavalli D, Taylor JL, Childs E, et al. “Health Is on the Back Burner:” Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs. J Gen Intern Med 2021;36(1):129–37.

Article  PubMed  Google Scholar 

Heidari O, Tormohlen K, Dangerfield DT, Tobin KE, Farley JE, Aronowitz SV. Barriers and facilitators to primary care engagement for people who inject drugs: A systematic review. J of Nursing Scholarship 2022;55:605–22. Available from: https://onlinelibrary.wiley.com/doi/10.1111/jnu.12863

Ross LE, Vigod S, Wishart J, et al. Barriers and facilitators to primary care for people with mental health and/or substance use issues: a qualitative study. BMC Fam Pract 2015;16(1):135.

Article  PubMed  PubMed Central  Google Scholar 

National Academies of Sciences, Engineering, and Medicine. Medications for Opioid Use Disorder Save Lives [Internet]. Washington, D.C.: National Academies Press; 2019 [cited 2022 Feb 22]. Available from: https://doi.org/10.17226/25310

Barry MJ, Edgman-Levitan S. Shared Decision Making — The Pinnacle of Patient-Centered Care. N Engl J Med 2012;366(9):780–1.

Article  CAS  PubMed  Google Scholar 

Davis K, Schoenbaum SC, Audet A-M. A 2020 vision of patient-centered primary care. J Gen Intern Med 2005;20(10):953–7.

Article  PubMed  PubMed Central  Google Scholar 

Melin J, Nordin Å, Feldthusen C, Danielsson L. Goal-setting in physiotherapy: exploring a person-centered perspective. Physiother Theory Pract 2021;37(8):863–80.

Article  PubMed  Google Scholar 

Kuipers SJ, Nieboer AP, Cramm JM. Making care more patient centered; experiences of healthcare professionals and patients with multimorbidity in the primary care setting. BMC Fam Pract 2021;22:70.

Article  PubMed  PubMed Central  Google Scholar 

Hawk M, Coulter RWS, Egan JE, et al. Harm reduction principles for healthcare settings. Harm Reduct J 2017;14(1):70.

Article  PubMed  PubMed Central  Google Scholar 

Kelley AT, Incze MA, Baylis JD, et al. Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. Subst Abuse 2022;43(1):1286–99.

Article  CAS  Google Scholar 

Park SE, Grogan CM, Mosley JE, Humphreys K, Pollack HA, Friedmann PD. Correlates of Patient-Centered Care Practices at U.S. Substance Use Disorder Clinics. Psychiatr Serv Wash DC 2020;71(1):35–42.

Article  Google Scholar 

Press KR, Zornberg GZ, Geller G, Carrese J, Fingerhood MI. What patients with addiction disorders need from their primary care physicians: A qualitative study. Subst Abuse 2016;37(2):349–55.

Article  Google Scholar 

Alves PCG, Stevenson FA, Mylan S, Pires N, Winstock A, Ford C. How do people who use drugs experience treatment? A qualitative analysis of views about opioid substitution treatment in primary care (iCARE study). BMJ Open 2021;11(2):e042865.

Article  PubMed  PubMed Central  Google Scholar 

Alves P, Sales C, Ashworth M. Does outcome measurement of treatment for substance use disorder reflect the personal concerns of patients? A scoping review of measures recommended in Europe. Drug Alcohol Depend 2017;179:299–308.

Article  PubMed  Google Scholar 

Chai D, Rosic T, Panesar B, et al. Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder. JAMA Netw Open 2021;4(8):e2119600.

Article  PubMed  PubMed Central  Google Scholar 

Dennis BB, Sanger N, Bawor M, et al. A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder. Trials 2020;21:30.

Article  PubMed  PubMed Central  Google Scholar 

Neale J, Vitoratou S, Finch E, et al. DEVELOPMENT AND VALIDATION OF ‘SURE’: A PATIENT REPORTED OUTCOME MEASURE (PROM) FOR RECOVERY FROM DRUG AND ALCOHOL DEPENDENCE. Drug Alcohol Depend 2016;165:159–67.

Article  PubMed  PubMed Central  Google Scholar 

Sanger N, Panesar B, Rosic T, et al. The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials. Braz J Psychiatry 2020;43(2):138–46.

Article  PubMed Central  Google Scholar 

Sofaer S. Qualitative methods: what are they and why use them? Health Serv Res 1999;34(5 Pt 2):1101–18.

CAS  PubMed  PubMed Central  Google Scholar 

Dunham K, Giardina M, Kolod B, et al. Transitioning Clinical Care for People Who Use Drugs to Telemedicine: Lessons Learned One Year into the COVID-19 Pandemic. Telemed E-Health 2021;27(8):929–33.

Article  Google Scholar 

Riazi F, Toribio W, Irani E, et al. Community Case Study of Naloxone Distribution by Hospital-Based Harm Reduction Program for People Who Use Drugs in New York City. Front Sociol 2021;6:619683.

Article  PubMed  PubMed Central  Google Scholar 

Woodrell C, Weiss J, Branch A, et al. Primary Care-Based Hepatitis C Treatment Outcomes With First-Generation Direct-Acting Agents. J Addict Med 2015;9(5):405–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vu TM, Toribio W, Riazi F, et al. Increasing Access to Hepatitis C Virus Medications: A Program Model Using Patient Navigators and Specialty Pharmacy to Obtain Prior Authorization Approval. J Manag Care Spec Pharm 2018;24(4):329–33.

PubMed  Google Scholar 

Gardenier D, Woody A, Amory C, Weiss JJ. Interprofessional team-based approach to patients with chronic hepatitis C and personality disorder: Three case studies. Arch Psychiatr Nurs 2019;33(4):352–7.

Article  PubMed  Google Scholar 

Wang L, Weiss J, Ryan EB, Waldman J, Rubin S, Griffin JL. Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic. J Subst Abuse Treat 2021;124:108272.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ziff J, Vu T, Dvir D, et al. Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City. Harm Reduct J 2021;18(1):38.

Article  PubMed  PubMed Central  Google Scholar 

Hughes TM, Kalicki A, Huxley-Reicher Z, et al. A Medical Student-Led Model for Telephone-Based Opioid Overdose Education and Naloxone Distribution during the Covid-19 Pandemic. Subst Abuse 2022;43(1):988–92.

Article  CAS  Google Scholar 

Guba EG. Criteria for assessing the trustworthiness of naturalistic inquiries. ECTJ 1981;29(2):75–91.

Article  Google Scholar 

Moser A, Korstjens I. Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis. Eur J Gen Pract 2017;24(1):9–18.

Article  PubMed  PubMed Central  Google Scholar 

Rapp CA, Saleebey D, Sullivan WP. The Future of Strengths-Based Social Work. Adv Soc Work 2005;6(1):79–90.

Article  Google Scholar 

Maguire M, Delahunt B. Doing a thematic analysis: A practical, step-by-step guide for learning and teaching scholars. AISHE-J [Internet] 2017;9(3):3351–33514. Available from: https://ojs.aishe.org/index.php/aishe-j/article/view/335. Accessed 30 Oct 2022

Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3(2):77–101.

Article  Google Scholar 

Manen M van. Turning to the Nature of Lived Experience: Human Science for an Action Sensitive Pedagogy [Internet]. In: Researching Lived Experience. Routledge; 1997. Available from: https://doi.org/10.4324/9781315421056

Teherani A, Martimianakis T, Stenfors-Hayes T, Wadhwa A, Varpio L. Choosing a Qualitative Research Approach. J Grad Med Educ 2015;7(4):669–70.

Article  PubMed  PubMed Central  Google Scholar 

Willig C. Reflections on the Use of a Phenomenological Method. Qual Res Psychol 2007;4(3):209–25.

Article  Google Scholar 

Muncan B, Walters SM, Ezell J, Ompad DC. “They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J 2020;17:53.

Article  PubMed